LETTERS: Thalidomide facts

Mr Christopher Lingard
Monday 02 October 1995 18:02 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

From Mr Christopher Lingard

Sir: Roger Jones of Penn Pharmaceuticals (Magazine: "The return of thalidomide", 23 September) may well have spotted a lucrative niche market for his company's product but, as a commentator on the thalidomide parents' settlement with Distillers in the early Seventies, he displays a dangerous lack of comprehension.

The fact that thalidomide caused the birth defects was never questioned by Distillers, who simply maintained that it was unreasonable to expect them to have discovered that fact. To suggest, as Mr Jones does, that the parents only settled because they had evidence that weakened their own case is scurrilous nonsense.

The thalidomide parents were a disparate group who faced a multi-million- pound company with virtually unlimited resources to fight the case and who wielded that economic muscle in rather distasteful ways. The fact that the parents achieved a settlement at all reflects creditably on them.

Unfortunately, since the Seventies, the level of the settlement has proved inadequate. Perhaps as Mr Jones and the other pharmaceutical companies rake in their profits, they will reflect on the fight that the British victims are still waging for realistic compensation.

Yours faithfully,

Christopher Lingard

Legal Adviser

Thalidomide Action Group

Truro

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in